Organon & Co. (NYSE: OGN) stock fell -0.49% on Friday to $32.41 against a previous-day closing price of $32.57. With 2.15 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.5 million shares. During the session, the Drug Manufacturers – General company that operates in wider Healthcare sector, reached to the highest price of $33.05 whereas the lowest price it dropped to was $31.39. The 52-week range on OGN shows that it touched its highest point at $39.47 and its lowest point at $28.50 during that stretch. It currently has a 1-year price target of $38.57. With its current market cap of 8.46 billion, OGN has annualized dividend of $1.12 while the current yield stands at 3.46%.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of OGN was down-trending over the past week, with a drop of -0.12%, but this was down by -2.64% over a month. Three-month performance dropped to -2.35% while six-month performance fell -2.76%. The stock gained 13.20% in the past year, while it has gained 6.44% so far this year. A look at the trailing 12-month EPS for OGN yields 5.13 with Next year EPS estimates of 5.70. For the next quarter, that number is 1.25. This implies an EPS growth rate of -40.40% for this year and 8.72% for next year.
Float and Shares Shorts:
At present, 253.58 million OGN shares are outstanding with a float of 253.46 million shares on hand for trading. On Jul 14, 2022, short shares totaled 5.5 million, which was 2.17% higher than short shares on Jun 14, 2022. In addition to Mr. Kevin Ali as the firm’s CEO & Director, Mr. Matthew M. Walsh serves as its Exec. VP & CFO.
Through their ownership of 77.09% of OGN’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 51.85% of OGN, in contrast to 24.90% held by mutual funds. Shares owned by individuals account for 0.04%. As the largest shareholder in OGN with 11.09% of the stake, The Vanguard Group, Inc. holds 28,136,736 shares worth 28,136,736. A second-largest stockholder of OGN, BlackRock Fund Advisors, holds 12,284,502 shares, controlling over 4.84% of the firm’s shares. SSgA Funds Management, Inc. is the third largest shareholder in OGN, holding 11,958,385 shares or 4.72% stake. With a 2.95% stake in OGN, the Vanguard Total Stock Market Index is the largest stakeholder. A total of 7,476,631 shares are owned by the mutual fund manager. The Vanguard Small Cap Index Fund, which owns about 2.53% of OGN stock, is the second-largest Mutual Fund holder. It holds 6,407,622 shares valued at 216.26 million. Victory Port. – Floating Rate Fun holds 2.22% of the stake in OGN, owning 5,641,666 shares worth 190.41 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for OGN since 8 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 5 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With OGN analysts setting a high price target of $41.00 and a low target of $34.00, the average target price over the next 12 months is $38.14. Based on these targets, OGN could surge 26.5% to reach the target high and rise by 4.91% to reach the target low. Reaching the average price target will result in a growth of 17.68% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. OGN will report FY 2022 earnings on 02/16/2023. Analysts have provided yearly estimates in a range of $5.54 being high and $4.54 being low. For OGN, this leads to a yearly average estimate of $5.08. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Organon & Co. surprised analysts by $0.08 when it reported $1.25 EPS against a consensus estimate of $1.17. The surprise factor in the prior quarter was $0.35. Based on analyst estimates, the high estimate for the next quarter is $1.46 and the low estimate is $1.00. The average estimate for the next quarter is thus $1.23.
Summary of Insider Activity:
Insiders traded OGN stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 37 while that of sell transactions has risen to 36 over the past year. The total number of shares bought during that period was 179,693 while 67,898 shares were sold.